Pathways to early detection of cervical cancer for a multiethnic, indigent, emergency department population

Health Education and Behavior

Volumn 23, Issue 1 SUPPL., 1996, Pages 89-104

  Engelstad, Linda ^a   Bedeian, Katherine ^a   Schorr, Kimberley ^b   Stewart, Susan ^c  

^a HIGHLAND HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 5144229824     PISSN: 10901981     EISSN: 15526127     Source Type: Journal    
DOI: 10.1177/019584029602300607     Document Type: Article

References (40)

1. Baker DW, Stevens CD, Brook RH: Regular source of ambulatory care and medical care utilization by patients presenting to a public hospital emergency department. JAMA271:1909-1912, 1994.
2. Rask KJ, Williams MV, Parker RM, McNagny SE: Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA271:1931-1933, 1994.
3. Hiatt RA, Pasick RJ, Pérez-Stable EJ, McPhee SJ, Engelstad L, Lee M, Sabogal F, D'Onofrio CN, Stewart S: Pathways to early cancer detection in the multiethnic population of the San Francisco Bay Area. Health Educ Q23(suppl.):S10-S27, 1996.
4. American College of Obstetricians and Gynecologists: Recommendations on frequency of Pap test screening, in ACOG Committee Opinion 152. Washington, DC, American College of Obstetricians and Gynecologists, 1995.
5. Brinton LA, Fraumeni JF: Epidemiology of uterine cervical cancer. J Chron Dis39(12):1051-1065, 1986.
6. Bang KM, White JE, Gause BL, Leffall LD: Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer61:1255-1261, 1988.
7. Park DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer41:184-197, 1988.
8. Freeman HP: Cancer in the socioeconomically disadvantaged. Cancer39(5):266-288, 1989.
9. Makuc DM, Fried VM, Kleinman JC: National trend in the use of preventive health care by women. Am J Public Health79:21-26, 1989.
10. U.S. Department of Health and Human Services: Cancer Statistics Review, 1973-1991 (NIH Pub. No. 94-2789). Bethseda, MD, 1994.
11. Henschke UK, Leffall LD, Mason C, Reinhold AW, Schneider RL, White JE: Alarming increase of the cancer mortality in the U.S. black population 1950-1967. Cancer31(4):763-768, 1973.
12. Kleinman JC, Kopstein A: Who is being screened for cervical cancer?Am J Public Health71:73-76, 1981.
13. Office of Surveillance and Analysis and Cancer Prevention and Control Branch: Black-white differences in cervical cancer mortality-United States, 1980-1987. MMWR39:245-248, 1990.
14. Michielutte R, Dignan M, Bahnson J, Wells HB: The Forsyth County Cervical Cancer Prevention Project-II. Compliance with screening follow-up of abnormal cervical smears. Health Educ Res9(4):421-432, 1994.
15. Cushner I, Reading A, Bardzk J, Marcus A: An Evaluation of Three Interventions Designed to Increase Adherence Among Women With Normal Pap Smears. Paper presented at the American Public Health Association, Las Vegas, NV, September 1986.
16. Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, Engstrom P: Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol10:330-333, 1992.
17. Marcus A, Crane L, Kaplan C, Reading AE, Savage E, Gunning J, Berstein G, Berek JS: Improving adherence to screening follow-up among women with abnormal Pap smears: Results from a large clinic-based trial of three intervention strategies. Med Care30(3):216-230, 1992.
18. Vernon SW, Tilley BC, Neale, AV, Steinfeldt, L: Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer55:1563-1571, 1985.
19. Farley TA, Flannery JT: Late-stage diagnosis of breast cancer in women of lower socioeconomic status: Public health implications. Am J Prev Health79:1508-1512, 1989.
20. Doyle Y: A survey of the cervical screening service in a London district, including reasons for non-attendance, ethnic responses and views on the quality of the service. Soc Sci Med32:953-957, 1991.
21. McWhorter WP, Mayer WJ: Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health77:1515-1517, 1987.
22. Norman SA, Talbott EO, Kuller LH, Stolley PD, Dunn MS, Baffone K, Klionsky B, Weinberg GB: The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer. Arch Intern Med151:58-64, 1991.
23. Freeman HP, Muth BJ, Kerner JF: Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Practice3:19-30, 1995.
24. Dodds ME, Dowd SL, Mitchell-Beren M, Yarbrough M, Choi K: A breast cancer screening program in a community hospital. J Comm Health16(5):241-249, 1991.
25. Hogness CG, Engelstad LP, Linck LM, Schorr KA: Cervical cancer screening in an urban emergency department. Ann Emerg Med21(8):933-939, 1992.
26. Green LW, Kreuter MW, Deeds SG, Partridge KB: Health Education Planning: A Diagnostic Approach. Palo Alto, CA, Mayfield, 1980.
27. Prochaska JO, DiClemente, CC: Stages of change in the modification of problem behaviors, in Hersen M, Eisler RM, Miller PM (eds.): Progress in Behavior Modification. Sycamore, IL, Sycamore Publishing, 1992.
28. Fruchter RG, Rones K, Roth T, Webber CA, Camilien L, Boyec JG: Pap smear histories in a medical clinic: Accuracy of patients' self-reports. NY State J Med92(10):421-424, 1992.
29. McKenna MT, Speers M, Mallin K, Warnecke R: Agreement between patient self-reports and medical records for Pap smear histories. Amer J Prev Med8(5):287-291, 1992.
30. Suarez L, Goldman DA, Weiss NS: Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Amer J Prev Med11(2):94-98, 1995.
31. Kurman RJ, Soloman D: The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. New York, Springer-Verlag, 1994.
32. Kost ER, Snyder RR, Schwartz LE, Hankins GDV: The "less than optimal" cytology: Importance in obstetric patients and in a routine gynecologic population. Obstetrics & Gynecology81(1):127-130, 1993.
33. Kivlahan C, Ingram E: Papanicolaou smears without endocervical cells: Are they adequate?Acta Cytol30:258-260, 1985.
34. Mitchell H, Medley G: Longitudinal study of women with negative cervical smears according to endocervical status. Lancet337:265-267, 1991.
35. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman, MH: Interim guidelines for management of abnormal cervical cytology. JAMA271(23):1866-1869, 1994.
36. American College of Obstetricians and Gynecologists: Absence of Endocervical Cells on a Pap Test (ACOG Committee Opinion 153). Washington, DC, American College of Obstetricians and Gynecologists, 1995.
37. Nadel V: Emergency Departments: Unevenly Affected by Growth and Change in Patient Use (GAO/HRD Publication No. 93-94). Washington, DC, U.S. General Accounting Office, Human Resources Division, 1993.
38. Lane DS: Compliance with referrals from a cancer-screening project. J Fam Prac17:811-817, 1983.
39. Michielutte R, Diseker RA, Young LD, May WJ: Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med14:248-258, 1985.
40. Elkind AK, Haran L, Eardley A, Spencer B: Reasons for non-attendance for computer-managed cervical screening: Pilot interview. Soc Sci Med27:651-660, 1988.